Induction of wild-type p53, bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells

International Journal of Cancer

Volumn 76, Issue 2, 1998, Pages 259-266

  Sharma, Kamal ^a   Srikant, Coimbatore B ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; ENDONUCLEASE; LIPOCORTIN 5; OCTREOTIDE; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; CYTOSTASIS; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; DNA, NEOPLASM; ENDONUCLEASES; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; OCTREOTIDE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; SOMATOSTATIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032513507     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980413)76:2<259::AID-IJC14>3.0.CO;2-7     Document Type: Article

References (29)

1. 1 arrest by expression of the wild type p53 gene in small cell lung carcinoma. Cell Growth Differentiation, 7,879-886 (1995).
2. BARRY, A. and EASTMAN, A., Identification of deoxyribonuclease II as an endonuclea.se involved in apoptosis. Arch. Biochem. Biophys., 300, 440-450 (1993).
3. BUSCAIL, L., ESTéVE, J.-R, SAINT-LAURENT, N., BERTRAND, V., REISINE, T., O'CARROLL, A.-M., BELL, G.I., SCHALLY, A.V., VAYSSE, N. and SUSIM, C., Inhibition of cell proliferation by the somatostatin analog RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. nat. Acad. Sci. (Wash), 92, 1580-1584 (1995).
4. CANDI, E., MELINO, G., DE LAURENZI, V., PIACENTINI, M., GUERRERI, P., SPINEDI, A. and KNIGHT, R.A., Tamoxifen and somatostatin affect tumors by inducing apoptosis. Cancer Lett., 96, 141-145 (1995).
5. 1 cell cycle block. Endocrinology, 136, 4174-4181 (1995).
6. CHIARUGI, V., MAGNELLI, L., CINELLI, M. and BASI, G., Apoptosis and the cell cycle. Cell. mol. Biol. Res., 40,403-612 (1994).
7. 2+ associated with apoptosis. Methods Cell. Biol. 46, 41-55 (1995).
8. FLORIO, T., RIM, C., HERSHBERGER, R.E., LODA, M. and STORK, P.J.S., The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol. Endocrinol, 8, 1289-1297 (1994).
9. FLORIO, T., SCORZIELLO, A., FATTORE, M., DALTO, V., SALZANO, S., Rossi, G., BERLINGIERI, M.T., Fusco, A. and SCHETTINI, G., Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity-impairment of the somatostatinergic effects by stable expression of E1A viral oncogene. J. biol. Chem., 271, 6129-6136 (1996).
10. GALLARDO, D., DRAZEN, K.E. and MCBRIDE, W.H., Adenovirus-based transfer of wild type p53 gene increases ovarian tumor radiosensitivity. Cancer Res., 56, 4891-4893 (1996).
11. GOROSPE, M., ClRIELLI, C., WANG, X., SETH, P., CAPOGROSSI, M.C. and HOLBROOKE, N.J., p21 (Wafl/Cipl) protects against p53-mediated apoptosisofhuman melanoma cells. Oncogene, 14, 929-935 (1997).
12. HERMEKING, H., FUNK, J.O., REICHERT, M., ELLWART, J.W. and EICK, D., Abrogation of p53-induced cell cycle arrest by c-Myc. Evidence for an inhibitor of p21 (WAFI/CIP1/SDI1). Oncogene, 11, 1409-1415 (1995).
13. 3] octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology, 136, 3698-3706 (1995).
14. 3]-octreotide. J. mid. Med., 33, 652-658 (1992).
15. PAGLIACCI, M.C., TOGNELLINI, R., GRIGNANI, F. and NICOLETTI, I., Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology, 129, 2555-2562 (1991).
16. PATEL, Y.C., GREENWOOD, M.T., PANETTA, R., DEMCHYSHYN, L., NIZNIK, H.B. and SRIKANT, C.B., Mini review: The somatostatin receptor family. Life Sci., 57,1249-1265 (1995).
17. PATEL, Y.C., PANETTA, R., ESCHER, E.E., GREENWOOD, M.T. and SRIKANT, C.B., Expression of multiple somatostatin receptor genes in AtT-20 cells: evidence for a novel somatostatin-28 selective receptor subtype. J. biol. Chem., 269, 1506-1509 (1994).
18. PEARSON, D.A., LISTER-JAMES, J., MCBRIDE, W.J., WILSON, D.M., MARTEL, L.J., CIVITELLO, E.R., TAYLOR, J.E., MOVER, B.R. and DEAN, R.T., Somatostatin receptor binding peptides labeled with technitium-99m: chemistry and initial biological studies.J. Med. Chem., 39, 1361-1371 (1996).
19. REARDON, D.B., WOOD, S.L., BRAUTIGAN, D.L., BELL, G.I., DENT, P. and STURGILL, T.W., Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin. Biochem. J., 314,401-404 (1996).
20. SAKAKURA, C. and 14 OTHERS, Overexpression of Bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int. J. Cancer, 67, 101-105(1996).
21. SHARMA, K. and SRIKANT, C.B., G protein coupled receptor signaled apoptosis is associated with activation of a cation insensitive acidic endonuclease and intracellular acidification. Biochem. Biophys. Res. Commun., 252, 134-140(1998).
22. SHARMA, K., PATEL, Y.C. and SRIKANT, C.B., Subtype selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol. Endocrinol., 10, 1688-1696 (1996).
23. SHARMA, K., PATEL, Y.C. and SRIKANT, C.B., Subtype selective human somatostatin receptor (hSSTR) mediated cytostatic and cytotoxic actions involve different signaling mechanisms. In: Proc. of the 79th Annual Meeting of the Endocrine Society, Minneapolis, June, 1997. Abstr. PI-152 (1997).
24. SRIKANT, C.B., Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary tumor cells. Biochem. Biophys. Res. Comm., 209, 400-407 (1995).
25. SRIKANT, C.B. and SHEN, S.-H., Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTPIC to membranes in MCF-7 human breast cancer adenocarcinoma cells. Endocrinology, 137, 3461-3468 (1996).
26. VIKIC-TOPIC, S., RAISCH, K.-R, KVOLS, L.-K. and VUK-PAVLOVIC, S., Expression of somatostatin subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J. din. Endocrinol. Metab., 80, 2974-2479 (1995).
27. WAGNER, C., BARGOU, R.C., DANIEL, P.T., BOMMERT, K., MAPARA, M.Y., ROYER, H.D. and DORKEN, B., Induction of the death-promoting gene Bax-alpha sensitizes cultured breast cancer cells to drug-induced apoptosis. Int. J. Cancer, 67,138-141 (1996).
28. WALKER, P.R. and SIKORSKA, M., Eridonuclease activities, chromatin structure, and DNA degradation in apoptosis. Biochem. Cell Bioi, 72, 615-623 (1994).
29. Xu, Y., BRUNO, J.F. and BERELOWITZ, M., Estrogen regulates somatostatin receptor subtype 2 expression in human breast cancer cells. Endocrinology, 137, 5634-5640 (1996).